1. Home
  2. AMST vs PMCB Comparison

AMST vs PMCB Comparison

Compare AMST & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$0.88

Market Cap

6.1M

Sector

Technology

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.36

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
PMCB
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.3M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
AMST
PMCB
Price
$0.88
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
74.7K
★ 254.5K
Earning Date
10-27-2026
09-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.83
N/A
EPS
N/A
★ N/A
Revenue
★ $364,777.00
N/A
Revenue This Year
$19,089.81
N/A
Revenue Next Year
$22.86
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 230.24
N/A
52 Week Low
$0.77
$0.33
52 Week High
$3.90
$1.51

Technical Indicators

Market Signals
Indicator
AMST
PMCB
Relative Strength Index (RSI) 37.17 34.43
Support Level $0.77 $0.33
Resistance Level $1.11 $0.85
Average True Range (ATR) 0.04 0.03
MACD -0.01 -0.00
Stochastic Oscillator 25.56 15.68

Price Performance

Historical Comparison
AMST
PMCB

About AMST Amesite Inc.

Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: